Results 141 to 150 of about 814,420 (203)

Reply to Response by Tariq to "Association Between Proton Pump Inhibitor Use and Short-term Postoperative Complications Following Abdominoplasty: A Multi-Institutional Cohort Study". [PDF]

Aesthet Surg J Open Forum
Wolf Y, Zontag J, Skorochod R, Zontag N.
europepmc   +1 more source

Deprescribing proton pump inhibitors in long-term care: Outcomes of a pharmacist-led initiative. [PDF]

Explor Res Clin Soc Pharm
Muhana A, Assadi RA, Mahdi A, Fathy A, Farina M, Diab MJ.   +5 more
europepmc   +1 more source

Long-Term Proton Pump Inhibitor Therapy Is Common Among Older Adults: An 8-Year Finnish Nationwide Register Study. [PDF]

Drugs Aging
Minkkinen L, Kari H, Nurminen F, Leppänen J, Koskinen H.   +4 more
europepmc   +1 more source

Reprocessing Mass Spectra from Therapeutic Drug Monitoring to Unveil Proton Pump Inhibitor Use and Quantify Phenoconversion of Escitalopram Metabolism in CYP2C19-Genotyped Patients. [PDF]

Clin Pharmacol Ther
Hole K, Wollmann BM, Stingl JC, Molden E.   +3 more
europepmc   +1 more source

Proton pump inhibitors use and the risk of osteoporosis and fractures: A two-sample Mendelian randomization study. [PDF]

Medicine (Baltimore)
Li P, Wu R, Shi H.
europepmc   +1 more source

Erratum: Comment on "Evaluation of the Long-Term Administration of Proton Pump Inhibitors (PPIs) in the Mineral Nutrient's Bioavailability". [PDF]

ACS Omega
Cavalcante LN, Souza MHLP.
europepmc   +1 more source

Sustained proton-pump inhibitor exposure and incident age-related macular degeneration: a new-user, population-based cohort study. [PDF]

BMJ Open Ophthalmol
Bantounou MA, Emfietzoglou M, Baroutis KG, Starr MR, Miller JW, Vavvas DG.   +5 more
europepmc   +1 more source